США - англійська - NLM (National Library of Medicine)

taizhou yadai daily-use co., ltd - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - ethyl alcohol   antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. - in children less than 2 months of age. - on open skin wounds. stop use and ask a doctor if irritation or rash occurs. these may be signs of a serious condition.

США - англійська - NLM (National Library of Medicine)

taizhou yadai daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help decrease bacteria that potentially can cause disease for use when soap and water are not available

США - англійська - NLM (National Library of Medicine)

taizhou yadai daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - purmp onto hands, lteregrously for atleast 15second, rise and dry throughly disinfection sterilization

США - англійська - NLM (National Library of Medicine)

taizhou yadai daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help decrease bacteria on the skin recommended for repeated use

США - англійська - NLM (National Library of Medicine)

taizhou yadai daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help decrease bacteria on the skin recommended for repeated use

США - англійська - NLM (National Library of Medicine)

taizhou yadai daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antimicrobial hand sanitizer to help decrease bacteria on the skin

США - англійська - NLM (National Library of Medicine)

taizhou yadai daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help decrease bacteria on the skin recommended for repeated use

Європейський Союз - англійська - EMA (European Medicines Agency)

3m health care limited - rivastigmine - alzheimer disease - psychoanaleptics, , anticholinesterases - symptomatic treatment of mild to moderately severe alzheimer's dementia.

Сінгапур - англійська - HSA (Health Sciences Authority)

eisai (singapore) pte. ltd. - donepezil 20.98 mg eqv donepezil hydrochloride - tablet, film coated - 23 mg - donepezil 20.98 mg eqv donepezil hydrochloride 23 mg

Ізраїль - англійська - Ministry of Health

eli lilly israel ltd, israel - ramucirumab - concentrate for solution for infusion - ramucirumab 10 mg/ml - ramucirumab - gastric cancercyramza in combination with paclitaxel is indicated for the treatment of adult patients with advanced gastric cancer or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum and fluoropyrimidine chemotherapy. cyramza monotherapy is indicated for the treatment of adult patients with advanced gastric cancer or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum or fluoropyrimidine chemotherapy, for whom treatment in combination with paclitaxel is not appropriate.colorectal cancercyramza, in combination with folfiri (irinotecan, folinic acid, and 5-fluorouracil), is indicated for the treatment of adult patients with metastatic colorectal cancer (mcrc) with disease progression on or after prior therapy with bevacizumab, oxaliplatin and a fluoropyrimidine.non-small cell lung cancercyramza in combination with erlotinib is indicated for the first-line treatment of adult patients with metastatic non-small cell lung adenocarcinoma with activating epidermal growth factor receptor (egfr) mutations.cyramza in combination with docetaxel is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with disease progression after platinum-based chemotherapy.hepatocellular carcinomacyramza monotherapy is indicated for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have a serum alpha fetoprotein (afp) of ≥ 400 ng/ml and who have been previously treated with sorafenib.